US Patent 9249145 Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9249145

Patent Inventor Names

Haisheng Wang0

James D. Rodgers0

Stacey Shepard0

Yun-Long Li0

Date of Patent

February 2, 2016

Patent Application Number

12872925

Date Filed

August 31, 2010

Patent Citations Received

‌

US Patent 12071439 Process and intermediates for preparing a JAK inhibitor

‌

US Patent 11685731 Processes of preparing a JAK1 inhibitor

‌

US Patent 11833152 JAK1 pathway inhibitors for the treatment of cytokine-related disorders

‌

US Patent 11857563 Inhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease

‌

US Patent 11905275 Bipyrazole derivatives as JAK inhibitors

‌

US Patent 11905292 Process and intermediates for preparing a JAK inhibitor

‌

US Patent 11957661 JAK1 pathway inhibitors for the treatment of vitiligo

‌

US Patent 11992490 Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)

Patent Primary Examiner

‌

Susanna Moore

Patent abstract

The present invention provides heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 9249145 Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 9249145 Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors